UPDATE: Oppenheimer Downgrades Optimer Pharmaceuticals (OPTR) to Perform, Questions About Near-Term Growth
Tweet Send to a Friend
(Updated - October 9, 2012 8:19 AM EDT)
Oppenheimer downgraded Optimer Pharmaceuticals (NASDAQ: OPTR) from Outperform to Perform.
This article: 183 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer downgraded Optimer Pharmaceuticals (NASDAQ: OPTR) from Outperform to Perform.
This article: 183 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
